✦ LIBER ✦

Rationale and Design of MILES-3 and MILES-4 Studies: Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

✍ Scribed by Gridelli, Cesare; Rossi, Antonio; Di Maio, Massimo; Leo, Silvana; Filipazzi, Virginio; Favaretto, Adolfo G.; Burgio, Marco A.; Cinieri, Saverio; Bianco, Roberto; Ciardiello, Fortunato; Cavanna, Luigi; Bordonaro, Roberto; Costanzo, Raffaele; Sandomenico, Claudia; Gallo, Ciro; Perrone, Francesco; Morabito, Alessandro

Book ID: 121782628
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 327 KB
Volume: 15
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2013.11.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin and weekly paclitaxel double

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

✍ Elisabeth Quoix; Gérard Zalcman; Jean-Philippe Oster; Virginie Westeel; Eric Pic 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 274 KB

First line chemotherapy with gemcitabine

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule

✍ Quoix, Elisabeth; Breton, Jean-Luc; Ducoloné, Alain; Mennecier, Bertrand; Depier 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Randomized phase II trial of gefitinib o

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

✍ Morère, Jean-François; Bréchot, Jeanne-Marie; Westeel, Virginie; Gounant, Valeri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Motexafin Gadolinium (MGd) is Active as

Motexafin Gadolinium (MGd) is Active as a Single Agent and in Combination with Pemetrexed and Docetaxel in Advanced Non–Small-Cell Lung Cancer (NSCLC) Patients who Failed Platinum-Based Chemotherapy: Early Results of 3 Phase II Trials

✍ R.B. Natale; G. Nicholas; K. Pandya; M. Edelman; S.C. Phan; M.F. Renschler 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 443 KB

P-554 Randomized Phase II study of first

P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group

✍ Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB